Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to TARGETED THERAPIES

Oncology Learning Network

FLT3 Inhibitor Monotherapy Shows Promise as Strategy for Patients with High-Risk FLT3-Mutated AML

Hematology/Oncology November 13th 2023

Clinical Advances in Hematology & Oncology

Mosunetuzumab, the First Bispecific Approved for Follicular Lymphoma

Hematology/Oncology November 13th 2023

Pharmacy Practice News

Protecting Cancer Patients on the Precision Medicine Path

Clinical Pharmacology October 30th 2023

Modern Optometry

Managing Microcyst-Like Epithelial Keratopathy Related to Cancer Therapy

Optometry October 30th 2023

The New England Journal of Medicine

Stem-Cell Aging and Pathways to Precancer Evolution

Hematology/Oncology October 9th 2023


Study Sheds a New Light on Cancer Metastasis

Hematology/Oncology October 2nd 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form